TEMGESIC

Main information

  • Trade name:
  • TEMGESIC 0.2 mg sublingual tablet
  • Dosage:
  • 0.2 mg
  • Pharmaceutical form:
  • sublingual tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • TEMGESIC 0.2 mg sublingual tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Buprenorphine

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 8390
  • Authorization date:
  • 08-03-2007
  • Last update:
  • 26-07-2018